CD94

CD94

CD94 Overview

Molecule Name
Natural killer cells antigen CD94
Synonyms
CD94,KLRD1,KP43,NK cell receptor
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
KLRD1,Killer Cell Lectin Like Receptor D1,Killer Cell Lectin-Like Receptor Subfamily D, Member 1,CD94 Antigen,Killer Cell Lectin-Like Receptor Subfamily D Member 1,NK Cell Lectin-Like Receptor Subfamily D
Background
CD94(Natural killer cells antigen CD94) is also known as KLRD1, KP43, NK cell receptor, Killer cell lectin-like receptor subfamily D member 1. CD94 plays a role as a receptor for the recognition of MHC class I HLA-E molecules by NK cells and some cytotoxic T-cells. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. CD94 pairs with the NKG2 molecule as a heterodimer. The CD94/NKG2 complex, on the surface of natural killer cells interacts with Human Leukocyte Antigen (HLA)-E on target cells.

CD94 Product List

Species
  • Human(2)
  • Mouse(1)
  • Rat(1)
  • Rhesus macaque(1)
Tag
  • His Tag(4)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(5)
Conjugate
  • Unconjugated(5)
Grade
  • RUO(5)
Low Endotoxin
  • Yes(1)
  • No(4)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
CD94
Human CD94 Protein, Mouse IgG2a Fc Tag
Human
HEK293
SDS-PAGE

$410.00

100ug
CD94
Human CD94 Protein, His Tag, low endotoxin
Human
HEK293
SDS-PAGE

$410.00

100ug
CD94
Mouse CD94 Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$360.00

100ug
CD94
Rhesus macaque CD94 Protein, His Tag (MALS verified)
Rhesus macaque
HEK293
MALSSDS-PAGE

$410.00

100ug
CD94
Rat CD94 Protein, His Tag (MALS verified)
Rat
HEK293
MALSSDS-PAGE

$395.00

100ug
You Have Viewed 1-5 Of 5 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
DibotatugDR-01Phase 2 ClinicalDren Bio Inc
Alopecia Areata; Autoimmune Diseases of the Nervous System; Enteropathy-Associated T-Cell Lymphoma; Leukemia; Leukemia, Large Granular Lymphocytic; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Vitiligo
Details
JV-394JV-394Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Neoplasms
Details
Customer Reviews